As part of portfolio management reforms based on the Mitsubishi Chemical Holdings Group’s medium-term management plan APTSIS 20, Mitsubishi Chemical Corporation (MCC; Head office; Chiyoda-ku, Tokyo; President: Masayuki Waga) has concluded agreements to transfer its polymer flocculant sales business to MT AquaPolymer, Inc. (MTAP; Head office; Chiyoda-ku, Tokyo; President: Satoshi Shikama) and Hymo Corporation (Hymo; Head office; Chiyoda-ku, Tokyo; President:Yoshiyuki Mochizuki) (the two companies). Once the transfer is complete, the two companies will outsource the manufacture of polymer flocculants to MCC. The transfer is subject to obtaining approval from competition authorities.

MTAP is a leading Japanese manufacturer of polymer flocculants and handles the production and sale of the same types of products as those to be transferred. Hymo is a water treatment solution manufacturer that has a record of joint research and development with MCC on some of the products to be transferred. These agreements have been reached in the expectation that the handover to the two companies of extensive sales networks built up by MCC and certain manufacturing technologies will reinforce the polymer flocculant business, which is a strength of the two companies.

Details of products to be transferred and timing of the transfer are listed below.

Transfer to MTAP

Products to be transferred:

    Anionic, cationic, and amphoteric polymer flocculants and organic coagulants

Transfer scheduled for: March 31, 2021

Transfer to Hymo

Products to be transferred:

    N-vinylformamide, polyvinylamine

    Polyvinyl amidine-based polymer flocculants and organic coagulants 

    Liquid types of polymers including polymer flocculants, coagulants and fixing agents

    Deodorant and defoaming agents, dehydrating agents and inorganic coagulants, etc.

Transfer scheduled for: March 31, 2021